Cargando…

Epidemiology of small intestinal bacterial overgrowth

Small intestinal bacterial overgrowth (SIBO) is defined as an increase in the bacterial content of the small intestine above normal values. The presence of SIBO is detected in 33.8% of patients with gastroenterological complaints who underwent a breath test, and is significantly associated with smok...

Descripción completa

Detalles Bibliográficos
Autores principales:	Efremova, Irina, Maslennikov, Roman, Poluektova, Elena, Vasilieva, Ekaterina, Zharikov, Yury, Suslov, Andrey, Letyagina, Yana, Kozlov, Evgenii, Levshina, Anna, Ivashkin, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303511/ https://www.ncbi.nlm.nih.gov/pubmed/37389240 http://dx.doi.org/10.3748/wjg.v29.i22.3400

Ejemplares similares

Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
por: Maslennikov, Roman, et al.
Publicado: (2023)

Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge
por: Dmitrieva, Ksenia, et al.
Publicado: (2023)

Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
por: Maslennikov, Roman, et al.
Publicado: (2021)

Probiotics in hepatology: An update
por: Maslennikov, Roman, et al.
Publicado: (2021)

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)
por: Maslennikov, Roman, et al.
Publicado: (2021)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Immune disorders and rheumatologic manifestations of viral hepatitis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection
por: Maslennikov, Roman, et al.
Publicado: (2021)

Clostridioides difficile co-infection in patients with COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2022)

Diet and intestinal bacterial overgrowth: Is there evidence?
por: Souza, Claudineia, et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French Cohort
por: Plauzolles, Anne, et al.
Publicado: (2022)

Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial
por: Kovaleva, Aleksandra, et al.
Publicado: (2023)

Dos ataques de diarrea consecutivos en 15 pacientes de COVID-19: uno asociado con antibióticos posterior a uno viral
por: Maslennikov, R., et al.
Publicado: (2022)

Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one()
por: Maslennikov, R., et al.
Publicado: (2022)

Small intestinal bacterial overgrowth syndrome in children
por: Siniewicz-Luzeńczyk, Katarzyna, et al.
Publicado: (2015)

Small intestinal bacterial overgrowth in Alzheimer’s disease
por: Kowalski, Karol, et al.
Publicado: (2021)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
por: Kiseleva, Yana V, et al.
Publicado: (2023)

Link between hypothyroidism and small intestinal bacterial overgrowth
por: Patil, Anant D.
Publicado: (2014)

The duodenal microbiome is altered in small intestinal bacterial overgrowth
por: Leite, Gabriela, et al.
Publicado: (2020)

How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2022)

The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
por: Ivashkin, Vladimir, et al.
Publicado: (2023)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
por: Maslennikov, Roman, et al.
Publicado: (2023)

Small Intestinal Bacterial Overgrowth is Associated with Intestinal Inflammation in the Irritable Bowel Syndrome
por: DAVID, LILIANA, et al.
Publicado: (2014)

Small intestinal bacterial overgrowth in children with intestinal failure on home parenteral nutrition
por: McGrath, Kathleen H, et al.
Publicado: (2019)

Gastrointestinal complaints in runners are not due to small intestinal bacterial overgrowth
por: Schommer, Kai, et al.
Publicado: (2011)

Small Intestine Bacterial Overgrowth and Environmental Enteropathy in Bangladeshi Children
por: Donowitz, Jeffrey R., et al.
Publicado: (2016)

Role of Small Intestinal Bacterial Overgrowth in Functional Gastrointestinal Disorders
por: Choi, Chang Hwan, et al.
Publicado: (2016)

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
por: Augustyn, Monika, et al.
Publicado: (2019)

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update
por: Takakura, Will, et al.
Publicado: (2020)

Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management
por: Rao, Satish S. C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l3k8t1efct2kgg2tk7s1vcrhu6